Reportstack's new report focuses on the adoption patterns of surgical biopsies, fine needle aspiration (FNA) devices, core needle biopsy (CNB) devices, and vacuum-assisted biopsy (VAB) devices in the diagnosis of breast, prostate, lung, liver, and thyroid cancers in the 10 major global markets, which include the United States, France, Germany, Italy, Spain, the United Kingdom, Japan, Brazil, China, and India.(PRWeb February 19, 2014)Read the full story at http://www.prweb.com/releases/2014/02/prweb11597684.htm